Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Feb;31(2):137-44.
doi: 10.1038/aps.2009.196.

Baicalin attenuates oxygen-glucose deprivation-induced injury by inhibiting oxidative stress-mediated 5-lipoxygenase activation in PC12 cells

Affiliations

Baicalin attenuates oxygen-glucose deprivation-induced injury by inhibiting oxidative stress-mediated 5-lipoxygenase activation in PC12 cells

Cheng-tan Li et al. Acta Pharmacol Sin. 2010 Feb.

Abstract

Aim: To determine whether the flavonoid baicalin attenuates oxygen-glucose deprivation (OGD)-induced injury by inhibiting oxidative stress-mediated 5-lipoxygenase (5-LOX) activation in PC12 cells.

Methods: The effects of baicalin and the 5-LOX inhibitor zileuton on the changes induced by OGD/recovery or H(2)O(2) (an exogenous reactive oxygen species [ROS]) in green fluorescent protein-5-LOX-transfected PC12 cells were compared.

Results: Both baicalin and zileuton attenuated OGD/recovery- and H(2)O(2)-induced injury and inhibited OGD/recovery-induced production of 5-LOX metabolites (cysteinyl leukotrienes) in a concentration-dependent manner. However, baicalin did not reduce baseline cysteinyl leukotriene levels. Baicalin also reduced OGD/recovery-induced ROS production and inhibited 5-LOX translocation to the nuclear envelope and p38 phosphorylation induced by OGD/recovery and H(2)O(2). In contrast, zileuton did not show these effects.

Conclusion: Baicalin can inhibit 5-LOX activation after ischemic injury, which may partly result from inhibition of the ROS/p38 mitogen-activated protein kinase pathway.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Effects of baicalin and zileuton on cell injury induced by OGD/recovery in PC12 cells. Cell viability was reduced after 2-h OGD and 24-h recovery in both GFP- and GFP-5-LOX-transfected cells. (A and B) Viability was significantly lower in GFP-5-LOX-transfected cells than in GFP-transfected cells. Baicalin and zileuton attenuated OGD/recovery-induced injury in both type cells in a concentration-dependent manner. (C) Cell death (necrosis) was evaluated by PI fluorescence staining in GFP-5-LOX-transfected PC12 cells (Scale bar=40 μm). (D and E) Baicalin and zileuton inhibited OGD/recovery-induced cell death in a concentration-dependent manner. Data are reported as mean±SD. n=15−17 (A and B) or 4 (D and E). bP<0.05, cP<0.01 vs corresponding control; eP<0.05, fP<0.01 vs OGD/recovery alone; hP<0.05, iP<0.01 vs GFP-transfected cells.
Figure 2
Figure 2
Effects of baicalin and zileuton on 5-LOX translocation after OGD/recovery in GFP-5-LOX-transfected PC12 cells. (A) GFP-5-LOX was translocated into the nuclear envelope after 2-h OGD and 2-h recovery, which was inhibited by baicalin (1 μmol/L) but not by zileuton (1 μmol/L). Scale bar=40 μm. (B and C) Concentration-dependent results are summarized as mean±SD. n=6. bP<0.05, cP<0.01 vs OGD/recovery alone. ND, not detectable.
Figure 3
Figure 3
Effects of baicalin and zileuton on production of CysLTs after OGD/recovery in GFP-5-LOX-transfected PC12 cells. Baicalin (Ba, 10 μmol/L) reduced only the increased production whereas zileuton (Zi, 10 μmol/L) reduced both baseline and the increased production of CysLTs after OGD/recovery. Data are reported as mean±SD. n=4. bP<0.05, cP<0.01 vs control (no treatment). fP<0.01 vs OGD/recovery alone.
Figure 4
Figure 4
Effects of baicalin and zileuton on OGD/recovery-induced ROS production and H2O2-reduced viability in PC12 cells. (A and B) ROS production was determined after 2-h OGD and 0.5-h recovery in the absence or presence of baicalin and zileuton in wild-type PC12 cells. Baicalin, but not zileuton, inhibited ROS production. (C and D) Exposure to H2O2 (160 mol/L) for 24 h reduced cell viability in GFP-5-LOX-transfected PC12 cells. Over-expression of 5-LOX augmented H2O2- induced injury in PC12 cells. Baicalin (C) and zileuton (D) attenuated the reduced viability. Data are reported as mean±SD. n=8. bP<0.01, cP<0.01 vs control; eP<0.05, fP<0.01 vs OGD alone; hP<0.05, iP<0.01 vs GFP-transfected cells.
Figure 5
Figure 5
Effects of baicalin and zileuton on H2O2-induced 5-LOX translocation in GFP-5-LOX-transfected PC12 cells. (A) H2O2 (160 μmol/L)–induced 5-LOX translocation was significantly inhibited by baicalin (1 μmol/L) but not by zileuton (1 μmol/L). Scale bar=20 μm. (B and C) Concentration-dependent results are reported as mean±SD. n=6−8. cP<0.01 vs H2O2 alone. ND, not detectable.
Figure 6
Figure 6
Effects of baicalin and zileuton on OGD/recovery- or H2O2-induced p38 phosphorylation in GFP-5-LOX transfected PC12 cells. Phosphorylation of p38 was inhibited by baicalin (1 and 10 μmol/L) but not by zileuton after 2-h OGD/1.5-h recovery (A) and exposure to H2O2 (160 μmol/L) for 20 min (B). Data are reported as mean±SD. n=4−6. bP<0.05, cP<0.01 vs corresponding control; eP<0.05, fP<0.01 vs OGD/recovery or H2O2 alone. ND, not detectable.

Similar articles

Cited by

References

    1. Murphy RC, Gijon MA. Biosynthesis and metabolism of leukotrienes. Biochem J. 2007;405:379–95. - PubMed
    1. Rubin P, Mollison KW. Pharmacotherapy of diseases mediated by 5-lipoxygenase pathway eicosanoids. Prostaglandins Other Lipid Mediat. 2007;83:188–97. - PubMed
    1. Radmark O, Samuelsson B. 5-lipoxygenase: regulation and possible involvement in atherosclerosis. Prostaglandins Other Lipid Mediat. 2007;83:162–74. - PubMed
    1. Adamjee J, Suh YJ, Park HS, Choi JH, Penrose JF, Lam BK, et al. Expression of 5-lipoxygenase and cyclooxygenase pathway enzymes in nasal polyps of patients with aspirin-intolerant asthma. J Pathol. 2006;209:392–9. - PubMed
    1. Friedman BS, Bel EH, Buntinx A, Tanaka W, Han YH, Shingo S, et al. Oral leukotriene inhibitor (MK-886) blocks allergen-induced airway responses. Am Rev Respir Dis. 1993;147:839–44. - PubMed

Publication types